Guest guest Posted January 3, 2008 Report Share Posted January 3, 2008 Wow, déjà-vu. I thought this already was a rule. I must have had the gift of foresight or something. I can’t believe this just became law. Kathy Saradarian, MD Branchville, NJ www.qualityfamilypractice.com Solo 4/03, Practicing since 9/90 Practice Partner 5/03 Low staffing From: [mailto: ] On Behalf Of Locke's in Colorado Sent: Thursday, January 03, 2008 1:00 AM To: Subject: Issuance of Multiple Prescriptions for Schedule II Controlled Substances --> RE: DEA question No time to clean up the formatting but here is the ruling. Read the attachment for the full meal deal. Locke, MD http://www.deadiversion.usdoj.gov/pubs/manuals/pract/pract_manual090506.pdf Issuance of Multiple Prescriptions for Schedule II Substances On September 6, 2006, the DEA published in the Federal Register a Notice of Proposed Rulemaking, which proposes to permit an individual practitioner to issue multiple prescriptions authorizing the patient to receive a total of up to a 90-day supply of a Schedule II controlled substance, provided that certain conditions are met. If and when this proposed rule becomes final, DEA will update this manual accordingly. http://www.asipp.org/11192007Newsupdate.html November 19, 2007 Important ASIPP Update Final Rule on Issuance of Multiple Prescriptions for Schedule II Controlled Substances ASIPP has received notification and is pleased to announce that as per DEA Administrator Tandy's promise, the notice regarding the Multiple Schedule II Rule, has now been prepared and will be published in the Federal Register on Nov. 19, 2007. The rule entitled, " Issuance of Multiple prescriptions for Schedule II Controlled Substance, " will take effect on Dec. 9, 2007. The final rule amends DEA's previous regulation to allow practitioners to provide individual patients with multiple prescriptions for a specific schedule II controlled substance, written on the same date, to be filled sequentially. The new rule allows physicians to write three separate prescriptions with staggered fill dates. Patients can still be given the equivalent of a 90-day prescription for schedule II controlled substances when medically appropriate. Federal Register Notice http://www.asipp.org/documents/72FR64921finalruleonissuanceofScheduleII.pdf Drug Enforcement Administration 21 CFR Part 1306 [Docket No. DEA–287F] RIN 1117–AB01 Issuance of Multiple Prescriptions for Schedule II Controlled Substances AGENCY: Drug Enforcement Administration (DEA), Department of Justice ACTION: Final rule. SUMMARY: The Drug Enforcement Administration (DEA) is finalizing a Notice of Proposed Rulemaking published on September 6, 2006 (71 FR 52724). In that document, DEA proposed to amend its regulations to allow practitioners to provide individual patients with multiple prescriptions, to be filled sequentially, for the same schedule II controlled substance, with such multiple prescriptions having the combined effect of allowing a patient to receive over time up to a 90-day supply of that controlled substance. DATES: Effective Date: This rule is effective December 19, 2007. snip-snip As the NPRM made clear, the proposed rule in no way changes longstanding federal law governing the issuance of prescriptions for controlled substances. As stated in the NPRM: ‘‘What is required, in each instance where a physician issues a prescription for any controlled substance, is that the physician properly determine there is a legitimate medical purpose for the patient to be prescribed that controlled substance and that the physician be acting in the usual course of professional practice.’’ (71 FR 52725, September 6, 2006). Further, this Final Rule itself contains the following statement: Nothing in this subsection shall be construed as mandating or encouraging individual practitioners to issue multiple prescriptions or to see their patients only once every 90 days when prescribing Schedule II controlled substances. Rather, individual practitioners must determine on their own, based on sound medical judgment, and in accordance with established medical standards, whether it is appropriate to issue ============================ § 1306.12 Refilling prescriptions; issuance of multiple prescriptions. (a) The refilling of a prescription for a controlled substance listed in Schedule II is prohibited. ((1) An individual practitioner may issue multiple prescriptions authorizing the patient to receive a total of up to a 90-day supply of a Schedule II controlled substance provided the following conditions are met: (i) Each separate prescription is issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice; (ii) The individual practitioner provides written instructions on each prescription (other than the first prescription, if the prescribing practitioner intends for that prescription to be filled immediately) indicating the earliest date on which a pharmacy may fill each prescription; (iii) The individual practitioner concludes that providing the patient with multiple prescriptions in this manner does not create an undue risk of diversion or abuse; (iv) The issuance of multiple prescriptions as described in this section is permissible under the applicable state laws; and (v) The individual practitioner complies fully with all other applicable requirements under the Act and these regulations as well as any additional requirements under state law. (2) Nothing in this paragraph ( shall be construed as mandating or encouraging individual practitioners to issue multiple prescriptions or to see their patients only once every 90 days when prescribing Schedule II controlled substances. Rather, individual practitioners must determine on their own, based on sound medical judgment, and in accordance with established medical standards, whether it is appropriate to issue multiple prescriptions and how often to see their patients when doing so. 3. Section 1306.14 is amended by adding a new paragraph (e) to read as follows: § 1306.14 Labeling of substances and filling of prescriptions. * * * * * (e) Where a prescription that has been prepared in accordance with section 1306.12( contains instructions from the prescribing practitioner indicating that the prescription shall not be filled until a certain date, no pharmacist may fill the prescription before that date. Dated: November 7, 2007. Michele M. Leonhart, Deputy Administrator. [FR Doc. E7–22558 Filed 11–16–07; 8:45 am] BILLING CODE 4410–09–P From: [mailto: ] On Behalf Of Annie Skaggs Sent: Wednesday, January 02, 2008 5:10 PM To: Subject: DEA question Lovely young lady in today, new patient, but daughter of established patients. She is 20, self pay and home on vacation from England. She just graduated with an MA from some school in London, and took a job there. Did her undergrad at Xavier in Cincinnati, and while there, got started on Adderall. Once she went to the UK, she says they don’t have Adderall available, so her parents have been buying it here and mailing it to her. They have been getting the prescriptions from the same doc who prescribed it in Cinci. She did not bring records, but brought the most recent Rx, which Kentucky pharmacies have started refusing to fill because they are not written on the special controlled substance Rx paper required in KY. I don’t doubt her story, or that she finds it beneficial. Her mom would probably do well on something for ADD too. My question is about the legal implications. The DEA says no refills on Adderall, we’re supposed to follow her monthly. We can no longer write “do not fill before___” on the Rx because the DEA says no. Obviously she can’t come in monthly. How much trouble can I get into by handing her folks a year’s worth of post-dated scripts? I recommended she speak to a UK pharmacy when she goes back about what IS available there, but if there is no option, what can I do to help her and not get myself into trouble? Thanks, Annie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.